T here is convincing evidence, based on animal and human experiments, population
studies, and clinical trials, that cholesterol-lowering intervention is important in the treatment …

The importance of several risk factors in the causation of coronary heart disease (CHD) is
well established. Three risk factors have been identified as dominant. These are cigarette …

Lipid-lowering with statins reduces disease progression, prevents myocardial infarction and
other hard end points, and prolongs survival. Data from large-scale trials with these agents …

Atherosclerotic vascular disease is the major cause of death and disability in adult men and
women living in the United States, where 13–14 million adults have a history of coronary …

Lowering cholesterol in patients with coronary heart disease: are we ready yet? - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

This past year, 1987, has seen publication of some important studies of the ability of
cholesterol-lowering therapies to prevent complications of coronary heart disease (CHD) 1 …

Coronary angiographic trials have demonstrated that the lowering of cholesterol slows the
progression of atherosclerosis, enhances atherosclerotic regression, limits the formation of …

For the second time the consensus text for lipid lowering therapy is revised. In angiographic
studies it was shown that a decrease in the total cholesterol as well as the low-density …

Although the management of cardiovascular disease contains numerous controversies,
there are two issues that cardiologists appear to agree on: the link between serum …

Some of the treatments we use in cardiology must be applied urgently, such as
cardiopulmonary resuscitation or thrombolytic therapy for myocardial infarction. The urgency …